Invesco Ltd. Immuno Gen, Inc. Transaction History

Invesco Ltd.

  • $499 Billion
  • Q3 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
SELL
$12.46 - $29.95 $2.5 Million - $6.02 Million
-200,845 Reduced 18.49%
885,323 $26.2 Million
Q3 2023

Nov 13, 2023
BUY
$14.09 - $19.87 $711,023 - $1 Million
50,463 Added 4.87%
1,086,168 $17.2 Million
Q2 2023

Aug 11, 2023
BUY
$3.75 - $20.05 $3.2 Million - $17.1 Million
853,637 Added 468.86%
1,035,705 $19.5 Million
Q1 2023

May 12, 2023
BUY
$3.67 - $4.92 $333,925 - $447,660
90,988 Added 99.9%
182,068 $699,000
Q4 2022

Feb 13, 2023
SELL
$4.55 - $6.31 $1,724 - $2,391
-379 Reduced 0.41%
91,080 $451,000
Q3 2022

Nov 14, 2022
BUY
$4.48 - $6.47 $22,677 - $32,751
5,062 Added 5.86%
91,459 $437,000
Q2 2022

Aug 15, 2022
BUY
$3.15 - $5.76 $6,646 - $12,153
2,110 Added 2.5%
86,397 $389,000
Q1 2022

May 16, 2022
BUY
$4.26 - $7.48 $1,128 - $1,982
265 Added 0.32%
84,287 $402,000
Q4 2021

Feb 14, 2022
SELL
$4.75 - $7.5 $39,040 - $61,642
-8,219 Reduced 8.91%
84,022 $624,000
Q3 2021

Nov 15, 2021
BUY
$5.02 - $6.59 $60,290 - $79,145
12,010 Added 14.97%
92,241 $524,000
Q2 2021

Aug 17, 2021
BUY
$5.79 - $8.6 $182,089 - $270,461
31,449 Added 64.47%
80,231 $529,000
Q1 2021

May 17, 2021
BUY
$6.5 - $10.53 $34,151 - $55,324
5,254 Added 12.07%
48,782 $395,000
Q4 2020

Feb 16, 2021
BUY
$3.7 - $7.66 $43,896 - $90,878
11,864 Added 37.47%
43,528 $281,000
Q3 2020

Nov 16, 2020
SELL
$3.45 - $4.89 $4.56 Million - $6.47 Million
-1,322,736 Reduced 97.66%
31,664 $114,000
Q2 2020

Aug 14, 2020
BUY
$3.32 - $5.34 $4.43 Million - $7.12 Million
1,334,164 Added 6593.02%
1,354,400 $6.23 Million
Q1 2020

May 15, 2020
SELL
$2.12 - $6.8 $819,969 - $2.63 Million
-386,778 Reduced 95.03%
20,236 $70,000
Q4 2019

Feb 14, 2020
BUY
$2.25 - $5.8 $915,781 - $2.36 Million
407,014 New
407,014 $2.08 Million
Q2 2019

Aug 14, 2019
SELL
$1.8 - $3.3 $31,017 - $56,865
-17,232 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$2.41 - $5.91 $949 - $2,328
394 Added 2.34%
17,232 $47,000
Q4 2018

Feb 14, 2019
BUY
$3.94 - $9.7 $66,341 - $163,328
16,838 New
16,838 $81,000

Others Institutions Holding IMGN

# of Institutions
8
Shares Held
1.41M
Call Options Held
0
Put Options Held
0
View Full List

About ImmunoGen, Inc.

IMGN Quotes by TradingView
  • Ticker IMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 220,712,992
  • Description
  • ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...
More about IMGN
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email